School of Medicine


Showing 1-5 of 5 Results

  • Heather Gentner

    Heather Gentner

    Finance Manager, Stem Cell Bio Regenerative Med Institute

    Current Role at Stanford I am Finance Manager for the Stem Cell Institute, in charge of our annual budget and sponsored and non-sponsored account portfolios. I supervise a team of 3.

    I was formerly Grants Manager for the Stanford Cancer Institute working with multiple PIs and handling financial details for the NCI Cancer Center Support Grant (CCSG). I also assisted the Finance Manager with special projects as requested, including annual budget process and Hyperion entry.

  • Siddhartha Mitra

    Siddhartha Mitra

    Senior Scientist, Stem Cell Bio Regenerative Med Institute

    Current Role at Stanford Senior Scientist.
    Research Team leader, brain tumor and human neural stem cell research
    Adult and Pediatric brain tumor CD47 therapeutic development group

  • Yukiko Murmann

    Yukiko Murmann

    Administrative Associate, Stem Cell Bio Regenerative Med Institute

    Current Role at Stanford Administrative Associate Nakauchi Lab
    Institute for Stem Cell Biology and Regenerative Medicine

  • Dr. Katharina Sophia Volz

    Dr. Katharina Sophia Volz

    Temp - Non-Exempt, Stem Cell Bio Regenerative Med Institute

    Bio Katharina Volz is a leading biomedical scientist. Katharina pioneered Stanford University's first PhD in Stem Cell Biology & Regenerative Medicine in 2015 and has been one of the fastest PhD recipients in the university's history, earning her degree in just 2.5 years. She is a WED United Nations Fellow and has been immersed in the field of biomedical sciences for the past 12 years, starting with her attendance at Germany's Valckenburg Biotechnology High school. She was the first German high school student to be accepted into a research program at Harvard University and has since been awarded several fellowships and awards to do research in 10 labs around the world. During her PhD thesis in the Red-Horse and Weissman labs, Katharina tracked the path of single cells in a developing mouse heart and identified the cell type that forms the coronary arteries and the signal required for this differentiation event. Her publication made it into the top 5 of the 2015 NAVBO list and had over 13K shares at international press including the Guardian and IFL science. During the last two semesters of her PhD, Katharina attended Stanford Business School's Startup Garage Program and founded OccamzRazor in 2015, a knowledge network with the mission to accelerate scientific discovery.

Stanford Medicine Resources: